| H-PDGS complexed with a 2-phenylimidazo[1,2-a]pyridine-6-carboxamide inhibitors | | homo-2-mer | 1-199 | 100 | 1×CL; 3×EDO; 2×GSH; 2×VH7; 2×MG; 3×NA; |
|
| hPGDS complexed with a quinoline-3-carboxamide | | homo-2-mer | 1-199 | 100 | 2×GSH; 2×KCD; |
|
| CRYSTAL STRUCTURE OF PROSTAGLANDIN D2 SYNTHASE IN COMPLEX WITH FRAGMENT 1A AT 1.84A RESOLUTION. | | homo-2-mer | 1-199 | 100 | 2×GSH; 1×MG; 2×QPN; 3×GOL; |
|
| Crystal structure of hH-PGDS with water displacing inhibitor | | homo-2-mer | 1-199 | 100 | 2×GSH; 1×MG; 1×7PQ; |
|
| H-PDGS complexed with a 2-phenylimidazo[1,2-a]pyridine-6-carboxamide inhibitors | | homo-2-mer | 1-199 | 100 | 2×GSH; 2×VH4; 2×MG; 2×NA; |
|
| H-PGDS complexed with inhibitor 1Y | | homo-2-mer | 1-199 | 100 | 2×GSH; 1×EDO; 2×TJG; |
|
| hPGDS complexed with an aza-quinoline | | homo-2-mer | 1-199 | 100 | 1×GSH; 2×SWS; |
|
| Crystal structure of hematopoietic prostaglandin D synthase in complex with U004 | | homo-2-mer | 2-199 | 100 | 1×MG; 2×GSH; 1×UX4; 1×GOL; |
|
| Crystal structure analysis of human hematopoietic prostaglandin D synthase complexed with HQL-79 | | homo-2-mer | 2-199 | 99.5 | 1×MG; 2×GSH; 2×HQL; 1×GOL; |
|
| Crystal structure of hematopoietic prostaglandin D synthase apo form | | homo-2-mer | 2-199 | 100 | 2×GSH; 2×GOL; 1×MG; |
|
| Crystal structure of hematopoietic prostaglandin D synthase | | homo-2-mer | 2-199 | 99.5 | 1×MG; 2×GSH; |
|
| Crystal structure of hH-PGDS with water displacing inhibitor | | homo-2-mer | 2-199 | 100 | 1×MG; 2×GSH; 1×9PQ; 1×DMS; |
|
| Crystal structure of hematopoietic prostaglandin D synthase in complex with F092 | | homo-2-mer | 2-199 | 100 | 2×GSH; 2×93C; 2×GOL; 1×MG; |
|
| Crystal structure of hH-PGDS with water displacing inhibitor | | homo-2-mer | 2-199 | 100.0 | 1×MG; 2×0O4; 2×GSF; |
|
| Crystal structure of hematopoietic prostaglandin D synthase | | homo-2-mer | 2-199 | 99.5 | 2×GSH; 1×CA; |
|
| Complex of human hematopoietic prostagandin D2 synthase (hH-PGDS) in complex with an active site in… | | homo-2-mer | 2-199 | 100 | 2×CWC; 2×GSH; 1×MG; |
|
| First Inhibitor Complex Structure of Human Hematopoietic Prostaglandin D Synthase | | homo-2-mer | 2-199 | 99.5 | 1×MG; 2×GSH; 2×O16; 3×GOL; |
|
| Structure of human prostaglandin D-synthase (hGSTS1-1) in complex with nocodazole | | homo-2-mer | 2-199 | 99.5 | 1×GSH; 1×NZO; 1×MG; |
|
| Complex structure of prostaglandin D2 synthase at 1.95A. | | homo-2-mer | 2-199 | 100 | 2×GSH; 1×VC3; |
|
| Complex structure of prostaglandin D2 synthase at 1.95A. | | homo-2-mer | 2-199 | 100 | 2×GSH; 1×ZZA; |
|
| Complex structure of prostaglandin D2 synthase at 1.95A. | | homo-2-mer | 2-199 | 100 | 2×GSH; 2×D25; |
|
| Human hematopoietic prostaglandin D synthase inhibitor complex structures | | homo-2-mer | 2-199 | 99.5 | 2×GSH; 1×CBD; 1×CA; |
|
| Human hematopoietic prostaglandin D synthase inhibitor complex structures | | homo-2-mer | 2-199 | 99.5 | 1×GSH; 1×GOL; 1×CA; 1×M4M; |
|
| Crystal structure of hH-PGDS with water displacing inhibitor | | homo-2-mer | 2-199 | 100 | 2×GSH; 2×0O5; 1×MG; |
|
| Complex of human hematopoietic prostagandin D2 synthase (hH-PGDS) in complex with an active site in… | | homo-2-mer | 2-199 | 99.5 | 2×M1W; 2×GSH; 1×MG; |
|
| An orally active inhibitor bound at the active site of HPGDS | | homo-2-mer | 2-199 | 100 | 2×GSH; 2×KXO; 1×MG; |
|
| Complex of human hematopoietic prostagandin D2 synthase (hH-PGDS) in complex with an active site in… | | homo-2-mer | 2-199 | 99.5 | 1×MG; 1×GSH; 1×KRX; |
|
| Complex structure of prostaglandin D2 synthase at 2.1A. | | homo-2-mer | 2-199 | 100 | 1×MG; 2×GSH; 1×D26; |
|
| Complex structure of prostaglandin D2 synthase at 2.2A. | | homo-2-mer | 2-199 | 100 | 2×GSH; 1×D27; |
|
| Complex structure of prostaglandin D2 synthase at 2.25A. | | homo-2-mer | 2-199 | 100 | 2×GSH; 1×D28; 1×MG; |
|